Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery

PURPOSE: Edoxaban is an oral, once-daily, selective, direct factor Xa inhibitor approved in Japan for the prevention of venous thromboembolism following major orthopedic surgery. Currently, edoxaban is in Phase III clinical development for the prevention of stroke and systemic embolic events in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroda, Yasufumi, Hirayama, Chie, Hotoda, Hitoshi, Nishikawa, Yasuhiro, Nishiwaki, Akinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794866/
https://www.ncbi.nlm.nih.gov/pubmed/24124376
http://dx.doi.org/10.2147/VHRM.S51244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794866/
https://www.ncbi.nlm.nih.gov/pubmed/24124376
http://dx.doi.org/10.2147/VHRM.S51244

Ejemplares similares